• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Point Nine: Investment Portfolio & Startup News

Point Nine

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Omnea raises £37m Series B led by Insight Partners and Khosla Ventures to build intelligent procurement orchestration platformOmnea raises £37m Series B led by Insight Partners and Khosla Ventures to build intelligent procurement orchestration platform
    Omnea
    17 Sept 2025

    Omnea raises £37m Series B led by Insight Partners and Khosla Ventures to build intelligent procurement orchestration platform

    Omnea develops AI-powered procurement software that acts as a single intake and orchestration layer, helping organisations manage supplier requests, workflows and risk across finance, legal and operations teams.

    Attio raises £39m Series B led by GV to scale AI-native CRM that understands every customerAttio raises £39m Series B led by GV to scale AI-native CRM that understands every customer
    Attio
    26 Aug 2025

    Attio raises £39m Series B led by GV to scale AI-native CRM that understands every customer

    Attio develops an AI-native CRM that lets teams design their own customer workflows, adapting the system to how they actually sell and operate.

Point Nine
    • Supply Chain
    • Enterprise
  • pointnine.com

More venture news

  • Subdial secures a £15m Series B led by Gresham House Ventures to buy and sell pre-owned watches
    Subdial
    16 Nov 2026

    Subdial secures a £15m Series B led by Gresham House Ventures to buy and sell pre-owned watches

    Series BConsumer
  • Griffin closes a £15m Series B led by Octagon Partners to add cards and stablecoin payments to its banking platform
    Griffin
    12 Nov 2026

    Griffin closes a £15m Series B led by Octagon Partners to add cards and stablecoin payments to its banking platform

    Series BFintech
  • T-Therapeutics closes a £100m Series B led by Advent Life Sciences and British Business Bank to take its cancer and autoimmune treatments into clinical trials
    T-Therapeutics
    5 Nov 2026

    T-Therapeutics closes a £100m Series B led by Advent Life Sciences and British Business Bank to take its cancer and autoimmune treatments into clinical trials

    Series BLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn